Bill Summary – FastDemocracy

   
      88(R) SB 2212 - Engrossed version - Bill Text
      
		By:  Blanco
            S.B.  No.  2212
         
               A BILL TO BE ENTITLED
            
               AN ACT
            
            relating to the disclosure by a pharmacy to a patient of certain 
         
            price information for a drug or biological product.
         
                          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         
                          SECTION  1.    Section 562.003, Occupations Code, is amended to 
         
            read as follows:
         
                          Sec.  562.003.    DISCLOSURE OF PRICE; PATIENT'S OPTION.   (a)   A 
         
            pharmacy shall disclose the lowest cost cash price at that pharmacy 
         
            for the drug or biological product prescribed to the patient.
         
                          (b)    If the price of a drug or biological product to a patient 
         
            is lower than the amount of the patient's copayment under the 
         
            patient's prescription drug insurance plan, the pharmacist shall 
         
            offer the patient the option of paying for the drug or biological 
         
            product at the lower price instead of paying the amount of the 
         
            copayment.
         
                          SECTION  2.    This Act takes effect September 1, 2023.
         
Statutes affected: 
Introduced: Occupations Code 562.003 (Occupations Code 562)
Senate Committee Report: Occupations Code 562.003 (Occupations Code 562)
Engrossed: Occupations Code 562.003 (Occupations Code 562)


	A BILL TO BE ENTITLED
	AN ACT
	relating to the disclosure by a pharmacy to a patient of certain
	price information for a drug or biological product.
	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
	SECTION 1. Section 562.003, Occupations Code, is amended to
	read as follows:
	Sec. 562.003. DISCLOSURE OF PRICE; PATIENT'S OPTION. (a) A
	pharmacy shall disclose the lowest cost cash price at that pharmacy
	for the drug or biological product prescribed to the patient.
	(b) If the price of a drug or biological product to a patient
	is lower than the amount of the patient's copayment under the
	patient's prescription drug insurance plan, the pharmacist shall
	offer the patient the option of paying for the drug or biological
	product at the lower price instead of paying the amount of the
	copayment.
	SECTION 2. This Act takes effect September 1, 2023.